New Models

The US National Cancer Institute is phasing out its panel of 60 human cancer cell lines in favor of fresh models, Nature News reports.

That panel of 60 cell lines has been in use for a quarter of a century and has been used to screen more than 100,000 compounds. But, as Nature News adds, when these lines were created, researchers had a different view of cancer

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.